Skip to main content

Advertisement

Table 2 Characteristics of the application process for Ethical approval across the various European countries involved in GenOSept

From: Methodological challenges in European ethics approvals for a genetic epidemiology study in critically ill patients: the GenOSept experience

Country National coordinator No of ICUs Is the ethics approval process centralized or local? In what form is the ethics application made? Which of the following are usual members of the ethics committees? Outcome of GenOSept application process: range of centres approved Month/Year ethics application submitted & decision received Additional info / modification National guidelines for Research in ICU pts
National or Regional EC Local EC Paper application Web-based Application Lay Medical Legal All units Some units Approval refused Submitted Approved or rejected Interval (months)
Austria Novak 1 02/07 09/07 7 a
Belgium Damas 7 02/06 05/06 3
Czech Re Sramek 8 07/05 07/05 < 1
Croatia Gasparovic 2 11/07 3/08 4
Estonia Sarapu 2 06/05 06/05 < 1
France Chiche 8 10/05 10/06 12
Germany Bloos 12 07/05 08/05 1
Greece Armanagidis 2 04/06 04/06 < 1
Hungary Bobek 10 10/05 09/07 24
Ireland Ryan 7 03/06 10/06 7
Israel Weiss 5 08/05 02/06 6
Italy Cotogni 24 01/06 03/06 2
NL Hazelzet 1 01/07 11/07 9
Poland Mikstacki/Tamowicz 22 05/05 06/05 1
Portugal Carneiro 0 08/05 08/06 < 1
Serbia Surbatovic 2 07/06 07/06 < 1
Spain Sirgo/Rello 19 07/05 08/05 1
UK Hinds 28 03/06 04/06 1
Totals 18 countries 160 11 10 17 1 14 18 13 14 3 1 Median interval = 1.5 months 7 9
  1. aAustria: the REC which received the application recommended inclusion only of those critically ill patients who had capacity to give consent